We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

TxCell and Trizell Amend Collaboration Agreement

News   May 01, 2015

 
TxCell and Trizell Amend Collaboration Agreement
 
 
 

RELATED ARTICLES

Alzheimer's Trafficking Defect Corrected in Rodents

News

UT Southwestern researchers have succeeded in neutralizing what they believe is a primary factor in late-onset Alzheimer’s disease, opening the door to development of a drug that could be administered before age 40, and taken for life, to potentially prevent the disease in 50 to 80 percent of at-risk adults.

READ MORE

Probiotic Gives Long-standing Protection Against Childhood Eczema

News

Giving a probiotic supplement to pregnant mothers and their infants significantly reduces the chances of a child developing eczema for the first 11 years of their life.

READ MORE

Drug Improves Outcomes & Survival Rates in Patients with Bone Marrow Cancer

News

In the largest study of its kind, researchers at Newcastle University have led national research into the treatment of patients with newly diagnosed myeloma. The results, published by The Lancet Oncology, show an improvement for those who received ongoing therapy with a drug called lenalidomide, compared to those not receiving it.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE